Thomas J. Lynch Jr. - Jun 21, 2023 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Director
Signature
/s /Allan Reine, M.D., Attorney-in-Fact
Stock symbol
FHTX
Transactions as of
Jun 21, 2023
Transactions value $
$0
Form type
4
Date filed
6/22/2023, 08:14 PM
Previous filing
Oct 31, 2022
Next filing
Jun 28, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FHTX Stock Option (right to buy) Award $0 +16K $0.00 16K Jun 21, 2023 Common Stock 16K $8.70 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.